AuthorCitation

A randomized, double-blind, placebo-controlled, phase II study of regorafenib vs placebo in advanced/metastatic, treatment-refractory liposarcoma: results from the SARC024 study.

Riedel, Richard F. , Lu, Yao , Attia, Steven , Ganjoo, Kristen N. , Livingston, Michael B. , Ward, John Harris, Rushing, Daniel A., Okuno, Scott H. , Keedy, Vicki L. , Ryan, Christopher W. , Maki, Robert G. , Maki, Robert G , Riedel, Richard F , Ballman, Karla V. , Loggers, Elizabeth T , Chow, Warren , Wright, Jennifer , Reed, Damon R. , Liebner, David A. , Mascarenhas, Leo , Davis, Lara E. , Reinke, Denise K.

Mayo Clinic

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: 11505-11505

10.1200/jco.2018.36.15_suppl.11505

A pilot randomized sham-controlled trial of MC5-A scrambler therapy in the treatment of chronic chemotherapy-induced peripheral neuropathy (CIPN).

Razzak, A. Rab, Ensminger, Jennifer, Saiki, Catherine, Loprinzi, Charles L. , Smith, Thomas J. , Blackford, Amanda

Mayo Clinic

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: e22206-e22206

10.1200/jco.2018.36.15_suppl.e22206

Physician experience and understanding of clinical trial adverse event attribution.

Storrrick, Elizabeth M., Jatoi, Aminah , Mandrekar, Sumithra J. , Le‐Rademacher, Jennifer

Mayo Clinic

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: e14524-e14524

10.1200/jco.2018.36.15_suppl.e14524

A phase I study to evaluate safety, tolerability, pharmacokinetics and activity of oraxol in patients (pts) with advanced malignancies.

Azad, Nilofer S. , Dy, Grace K. , Gallagher, Denise , Brennen, Caden, Cutler, David L. , Kramer, Douglas, Kwan, Rudolf, Fetterly, Gerald J., Adjei, Alex A. , Jimeno, Antonio , Wee, Wen , Lam, Elaine T. , Diamond, Jennifer R. , Opyrchal, Mateusz , Chan, Wing‐Kai

Mayo Clinic

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: 2526-2526

10.1200/jco.2018.36.15_suppl.2526

Association between adaptive immune signature and outcome in HER2-positive breast cancer treated with trastuzumab and lapatinib in the NCCTG-N9831 (Alliance) and NeoALTTO trials.

Chumsri, Saranya , Serie, Daniel, Kachergus, Jennifer M., Warren, Sarah , Colón‐Otero, Gerardo , Hilbers, Florentine , Dooren, Veerle Van, Holmes, Eileen , Werner, Olena, Huober, Jens , Baselga, José , Perez, Edith A. , Moreno‐Aspitia, Alvaro , Thompson, E. Aubrey , Mashadi-Hossein, Afshin , Partridge, Ann H. , Carey, Lisa A. , Cosimo, Serena Di , Sotiriou, Christos P. , Dueck, Amylou C.

Mayo Clinic

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: 577-577

10.1200/jco.2018.36.15_suppl.577

TBCRC026: Phase II clinical trial assessing the correlation of standardized uptake value (SUV) on positron emission tomography (PET) with pathological complete response (pCR) to pertuzumab and trastuzumab in patients with primary operable HER2-positive bre

Connolly, Roisín M. , Leal, Jeffrey P. , Sólnes, Lilja B. , Carpenter, Ashley , Gaffney, Katy, Liu, Minetta C. , Rimawi, Mothaffar F. , Specht, Jennifer M. , Storniolo, Anna Maria , Valero, Vicente , Camp, Melissa , Cimino‐Mathews, Ashley , Rimawi, Mothaffar , Specht, Jennifer , Huang, Chiung‐Yu , Gaffney, Katy, Abramson, Vandana G. , Carey, Lisa A. , Vaklavas, Christos , Miller, Robert S. , Wolff, Antonio C. , Wahl, Richard L. , Stearns, Vered

Mayo Clinic

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: 511-511

10.1200/jco.2018.36.15_suppl.511

Phase 1b/2 study of olaratumab plus gemcitabine and docetaxel for the treatment of advanced soft tissue sarcoma (STS) (ANNOUNCE 2): Phase 1b results.

Villalobos, Víctor M. , Tine, Brian Andrew Van, Dickson, Mark A. , Cronier, Damien M., Attia, Steven , Redondo, Andrés , Schwartz, Gary K. , Chmielowski, Bartosz , Peterson, Patrick M. , Wright, Jennifer

Mayo Clinic

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: 11542-11542

10.1200/jco.2018.36.15_suppl.11542

Randomized controlled trial of cryotherapy to prevent paclitaxel-induced peripheral neuropathy (RU221511I): An ACCRU trial.

Ruddy, Kathryn J. , Wilkinson, Mary, Woude, Amy C. Vander, Perdekamp, Maria T. Grosse, Dockter, Travis , Tan, Angelina D., Beutler, Andreas S. , Loprinzi, Charles L. , Le‐Rademacher, Jennifer , Lacouture, Mario E. , Onitilo, Adedayo A

Mayo Clinic

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: e22075-e22075

10.1200/jco.2018.36.15_suppl.e22075

Is there a role for older-patient-specific cancer clinical trials? A pooled analysis of 2277 older patients in adjuvant breast cancer trials (Alliance A151715).

Jatoi, Aminah , Hurria, Arti , Muss, Hyman B. , Cohen, Harvey Jay, Citron, Marc L., Budman, Daniel R., Partridge, Ann, Lafky, Jacqueline M., Dao, Dyda , Zemla, Tyler , Freedman, Rachel A. , Shulman, Lawrence N. , McMurray, Ryan P. , Carey, Lisa A. , Le‐Rademacher, Jennifer

Mayo Clinic

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: 10034-10034

10.1200/jco.2018.36.15_suppl.10034

Scrambler therapy for established chemotherapy-induced neuropathy: A randomized phase II trial.

Loprinzi, Charles L. , Majithia, Neil , Bendel, Markus A. , Beutler, Andreas S. , Strick, D. M., Tilburt, Jon C. , Le‐Rademacher, Jennifer , McMurray, Ryan P. , Lachance, Daniel Honore , Cheville, Andrea , Smith, Thomas J.

Mayo Clinic

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: 10016-10016

10.1200/jco.2018.36.15_suppl.10016

Citations

A randomized, double-blind, placebo-controlled, phase II study of regorafenib vs placebo in advanced/metastatic, treatment-refractory liposarcoma: results from the SARC024 study.

A pilot randomized sham-controlled trial of MC5-A scrambler therapy in the treatment of chronic chemotherapy-induced peripheral neuropathy (CIPN).

Razzak, A. Rab, Ensminger, Jennifer, Saiki, Catherine, Loprinzi, Charles L. , Smith, Thomas J. , Blackford, Amanda

Physician experience and understanding of clinical trial adverse event attribution.

Storrrick, Elizabeth M., Jatoi, Aminah , Mandrekar, Sumithra J. , Le‐Rademacher, Jennifer

A phase I study to evaluate safety, tolerability, pharmacokinetics and activity of oraxol in patients (pts) with advanced malignancies.

Azad, Nilofer S. , Dy, Grace K. , Gallagher, Denise , Brennen, Caden, Cutler, David L. , Kramer, Douglas, Kwan, Rudolf, Fetterly, Gerald J., Adjei, Alex A. , Jimeno, Antonio , Wee, Wen , Lam, Elaine T. , Diamond, Jennifer R. , Opyrchal, Mateusz , Chan, Wing‐Kai

Association between adaptive immune signature and outcome in HER2-positive breast cancer treated with trastuzumab and lapatinib in the NCCTG-N9831 (Alliance) and NeoALTTO trials.

TBCRC026: Phase II clinical trial assessing the correlation of standardized uptake value (SUV) on positron emission tomography (PET) with pathological complete response (pCR) to pertuzumab and trastuzumab in patients with primary operable HER2-positive bre

Phase 1b/2 study of olaratumab plus gemcitabine and docetaxel for the treatment of advanced soft tissue sarcoma (STS) (ANNOUNCE 2): Phase 1b results.

Villalobos, Víctor M. , Tine, Brian Andrew Van, Dickson, Mark A. , Cronier, Damien M., Attia, Steven , Redondo, Andrés , Schwartz, Gary K. , Chmielowski, Bartosz , Peterson, Patrick M. , Wright, Jennifer

Randomized controlled trial of cryotherapy to prevent paclitaxel-induced peripheral neuropathy (RU221511I): An ACCRU trial.

Ruddy, Kathryn J. , Wilkinson, Mary, Woude, Amy C. Vander, Perdekamp, Maria T. Grosse, Dockter, Travis , Tan, Angelina D., Beutler, Andreas S. , Loprinzi, Charles L. , Le‐Rademacher, Jennifer , Lacouture, Mario E. , Onitilo, Adedayo A

Is there a role for older-patient-specific cancer clinical trials? A pooled analysis of 2277 older patients in adjuvant breast cancer trials (Alliance A151715).

Jatoi, Aminah , Hurria, Arti , Muss, Hyman B. , Cohen, Harvey Jay, Citron, Marc L., Budman, Daniel R., Partridge, Ann, Lafky, Jacqueline M., Dao, Dyda , Zemla, Tyler , Freedman, Rachel A. , Shulman, Lawrence N. , McMurray, Ryan P. , Carey, Lisa A. , Le‐Rademacher, Jennifer

Scrambler therapy for established chemotherapy-induced neuropathy: A randomized phase II trial.

Loprinzi, Charles L. , Majithia, Neil , Bendel, Markus A. , Beutler, Andreas S. , Strick, D. M., Tilburt, Jon C. , Le‐Rademacher, Jennifer , McMurray, Ryan P. , Lachance, Daniel Honore , Cheville, Andrea , Smith, Thomas J.